Literature DB >> 20842159

Framingham cardiovascular risk profile correlates with impaired hippocampal and cortical vasoreactivity to hypercapnia.

Lidia Glodzik1, Henry Rusinek, Miroslaw Brys, Wai H Tsui, Remigiusz Switalski, Lisa Mosconi, Rachel Mistur, Elizabeth Pirraglia, Susan de Santi, Yi Li, Alexander Goldowsky, Mony J de Leon.   

Abstract

Vascular risk factors affect cerebral blood flow (CBF) and cerebral vascular reactivity, contributing to cognitive decline. Hippocampus is vulnerable to both Alzheimer's disease (AD) pathology and ischemia; nonetheless, the information about the impact of vascular risk on hippocampal perfusion is minimal. Cognitively, healthy elderly (NL=18, 69.9±6.7 years) and subjects with mild cognitive impairment (MCI=15, 74.9±8.1 years) were evaluated for the Framingham cardiovascular risk profile (FCRP). All underwent structural imaging and resting CBF assessment with arterial spin labeling (ASL) at 3T magnetic resonance imaging (MRI). In 24 subjects (NL=17, MCI=7), CBF was measured after a carbon dioxide rebreathing challenge. Across all subjects, FCRP negatively correlated with hippocampal (ρ=-0.41, P=0.049) and global cortical (ρ=-0.46, P=0.02) vasoreactivity to hypercapnia (VR(h)). The FCRP-VR(h) relationships were most pronounced in the MCI group: hippocampus (ρ=-0.77, P=0.04); global cortex (ρ=-0.83, P=0.02). The FCRP did not correlate with either volume or resting CBF. The hippocampal VR(h) was lower in MCI than in NL subjects (Z=-2.0, P=0.047). This difference persisted after age and FCRP correction (F([3,20])=4.6, P=0.05). An elevated risk for vascular pathology is associated with a reduced response to hypercapnia in both hippocampal and cortical tissue. The VR(h) is more sensitive to vascular burden than either resting CBF or brain volume.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20842159      PMCID: PMC3049521          DOI: 10.1038/jcbfm.2010.145

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  46 in total

Review 1.  Hippocampus: cognitive processes and neural representations that underlie declarative memory.

Authors:  Howard Eichenbaum
Journal:  Neuron       Date:  2004-09-30       Impact factor: 17.173

2.  Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease.

Authors:  A Convit; M J De Leon; C Tarshish; S De Santi; W Tsui; H Rusinek; A George
Journal:  Neurobiol Aging       Date:  1997 Mar-Apr       Impact factor: 4.673

3.  Estimation of cerebrovascular reactivity using transcranial Doppler, including the use of breath-holding as the vasodilatory stimulus.

Authors:  H S Markus; M J Harrison
Journal:  Stroke       Date:  1992-05       Impact factor: 7.914

4.  Decreased cerebrovascular dilatory capacity in subjects with asymptomatic periventricular hyperintensities.

Authors:  Y Isaka; M Okamoto; K Ashida; M Imaizumi
Journal:  Stroke       Date:  1994-02       Impact factor: 7.914

5.  Brief Cognitive Rating Scale (BCRS).

Authors:  B Reisberg; S H Ferris
Journal:  Psychopharmacol Bull       Date:  1988

6.  Vascular risk factors, atherosclerosis, cerebral white matter lesions and cerebral perfusion in a population-based study.

Authors:  J J Claus; M M Breteler; D Hasan; E P Krenning; M L Bots; D E Grobbee; J C van Swieten; F van Harskamp; A Hofman
Journal:  Eur J Nucl Med       Date:  1996-06

7.  Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension.

Authors:  D L Sparks; S W Scheff; H Liu; T M Landers; C M Coyne; J C Hunsaker
Journal:  J Neurol Sci       Date:  1995-08       Impact factor: 3.181

8.  Vasoreactivity in patients with periventricular white matter lucency.

Authors:  P Bönöczk; G Panczel; Z Nagy
Journal:  Acta Neurol Scand       Date:  2004-10       Impact factor: 3.209

9.  Predictors of carotid stenosis in older adults with and without isolated systolic hypertension.

Authors:  K Sutton-Tyrrell; H G Alcorn; S K Wolfson; S F Kelsey; L H Kuller
Journal:  Stroke       Date:  1993-03       Impact factor: 7.914

10.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.

Authors:  F Fazekas; J B Chawluk; A Alavi; H I Hurtig; R A Zimmerman
Journal:  AJR Am J Roentgenol       Date:  1987-08       Impact factor: 3.959

View more
  30 in total

1.  Arterial spin labeling MRI: an emerging biomarker for Alzheimer's disease and other neurodegenerative conditions.

Authors:  David A Wolk; John A Detre
Journal:  Curr Opin Neurol       Date:  2012-08       Impact factor: 5.710

Review 2.  Contributions of Aging to Cerebral Small Vessel Disease.

Authors:  T Michael De Silva; Frank M Faraci
Journal:  Annu Rev Physiol       Date:  2019-10-16       Impact factor: 19.318

3.  Use of total cerebral blood flow as an imaging biomarker of known cardiovascular risks.

Authors:  J Richard Jennings; Alicia F Heim; Dora Chieh-Hsin Kuan; Peter J Gianaros; Matthew F Muldoon; Stephen B Manuck
Journal:  Stroke       Date:  2013-07-23       Impact factor: 7.914

4.  Association of Cardiovascular Risk Factors with Cerebral Perfusion in Whites and African Americans.

Authors:  Lindsay R Clark; Megan Zuelsdorff; Derek Norton; Sterling C Johnson; Mary F Wyman; Laura M Hancock; Cynthia M Carlsson; Sanjay Asthana; Susan Flowers-Benton; Carey E Gleason; Heather M Johnson
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

5.  Acid-Sensing Ion Channels: Novel Mediators of Cerebral Vascular Responses.

Authors:  Frank M Faraci; Rebecca J Taugher; Cynthia Lynch; Rong Fan; Subhash Gupta; John A Wemmie
Journal:  Circ Res       Date:  2019-08-27       Impact factor: 17.367

Review 6.  The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer's Disease.

Authors:  Chelsea C Hays; Zvinka Z Zlatar; Christina E Wierenga
Journal:  Cell Mol Neurobiol       Date:  2016-02-22       Impact factor: 5.046

7.  Frontocingulate cerebral blood flow and cerebrovascular reactivity associated with antidepressant response in late-life depression.

Authors:  Margarita Abi Zeid Daou; Brian D Boyd; Manus J Donahue; Kimberly Albert; Warren D Taylor
Journal:  J Affect Disord       Date:  2017-03-16       Impact factor: 4.839

8.  Reduced Slow-Wave Sleep Is Associated with High Cerebrospinal Fluid Aβ42 Levels in Cognitively Normal Elderly.

Authors:  Andrew W Varga; Margaret E Wohlleber; Sandra Giménez; Sergio Romero; Joan F Alonso; Emma L Ducca; Korey Kam; Clifton Lewis; Emily B Tanzi; Samuel Tweardy; Akifumi Kishi; Ankit Parekh; Esther Fischer; Tyler Gumb; Daniel Alcolea; Juan Fortea; Alberto Lleó; Kaj Blennow; Henrik Zetterberg; Lisa Mosconi; Lidia Glodzik; Elizabeth Pirraglia; Omar E Burschtin; Mony J de Leon; David M Rapoport; Shou-En Lu; Indu Ayappa; Ricardo S Osorio
Journal:  Sleep       Date:  2016-11-01       Impact factor: 5.849

Review 9.  Cerebrovascular reactivity to carbon dioxide in Alzheimer's disease.

Authors:  Lidia Glodzik; Catherine Randall; Henry Rusinek; Mony J de Leon
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

10.  Effects of aging on slow-wave sleep dynamics and human spatial navigational memory consolidation.

Authors:  Ricardo S Osorio; Indu Ayappa; Andrew W Varga; Emma L Ducca; Akifumi Kishi; Esther Fischer; Ankit Parekh; Viachaslau Koushyk; Po Lai Yau; Tyler Gumb; David P Leibert; Margaret E Wohlleber; Omar E Burschtin; Antonio Convit; David M Rapoport
Journal:  Neurobiol Aging       Date:  2016-03-19       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.